Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...

The CXCR6/CXCL16 signalling axis represents a pivotal mediator in the intricate interplay between immune responses, tumour progression and vascular pathology. CXCL16 exists both as a membrane-bound ...

The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on ...

Breast cancer remains one of the most prevalent malignancies worldwide, with approximately 2.3 million new cases diagnosed annually. Cytokines - small ...

Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used ...

Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate cancer cells—an important process that may help explain how some tumors progress ...

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...

The discovery of a vulnerability in pancreatic cancer offers hope for the development of innovative targeted therapies.

A new preclinical study found that inhibiting the enzyme LSD1 can activate the skin’s immune system and suppress tumor growth ...

This Research Topic focuses on cancers originating outside the central nervous system across the lifespan (including paediatric, adolescent, and adult ...

A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an ...